Contract Assay Service
StemCell Technologies is the recognized leader in the research and development of hematopoietic progenitor assays and related products. Our extensive experience and expertise is now available through the Contract Assay Service.
For more information, visit our website or email firstname.lastname@example.org.
story : Embryonic Stem Cells Correct Congenital Heart Defect in Mouse Embryos
story : Boy Cured by Stem Cells of Brother Born to Help Him
Gene Therapy for Erectile Dysfunction on Horizon
Harvard Seeks Permission to Clone Human Embryos to Make Stem Cells
Reconstituted Blood Better For Young Hearts
Stem Cells Mend Hearts at a Distance
Stem Cells Derived from Skin May Soon Be Used to Treat Brain Tumours
Stem Cells Secrete Healing Chemicals
Technique For Genetically Modifying Blood Stem Cells Brings Cure For Blood Diseases Closer
Researchers Provide Road Map For Generating B Cells From Stem Cells
Results of Islet Transplant Study Now Available
Taken from Teeth, Stem Cells Regenerate Tissue
Researchers have isolated stem cells from the ligament that holds human teeth in place and shown that, in laboratory mice, these cells are able to grow new ligament cells.
U-M Team Treating Mouth Wounds By Engineering Tissue Grafts
Scientists Use Embryonic Stem Cells To Prevent Birth Defect Death in Mouse Embryos
Stem Cell Research for Stroke
Umbilical Cord Stem Cells Can Save Lives
Unlike embryonic stem cells, those drawn from umbilical cords are treating diseases -and without any controversy
The Potential of Hematopoietic Stem Cell Therapy in Hepatology: A Critical Review
Derivation of Functional Endothelial Progenitor Cells from Human Umbilical Cord Blood Mononuclear Cells Isolated by a Novel Cell Filtration Device (Letter to the Editor)
Biologists Seek Consensus on Guidelines for Stem-cell Research
The Societal Unit Cost of Allogenic Red Blood Cells and Red Blood Cell Transfusion in Canada
Acute Lung Injury After Allogeneic Stem Cell Transplantation: Is the Lung a Target of Acute Graft-Versus-Host Disease?
Favorable Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Acute Promyelocytic Leukemia in Childhood
Contribution of Bone Marrow-Derived Cells to Skin: Collagen Deposition and Wound Repair
Fusarium Dimerum Infection in a Stem Cell Transplant Recipient Treated Successfully with Voriconazole
Bush and Kerry on the Issues: Stem-cell Research
UN Considers Cloning Again
Scientists, Patients Fight UN Stem Cell Study Ban
Student Society for Stem Cell Research: Global Petition to the UN for Stemcell Research
UN 'Must Ignore Cloning Ban Call'
The United Nations should ignore a call by George Bush to ban all forms of human cloning, say UK scientists.
France Welcomes Human Stem Cell Research
Network Aims to Boost Swiss Stem Cell Research
Malachite Management has joined forces with an established and reputable author to bring you a report outlining the very latest in the Cell Therapy industry. "Cell Therapy - Technologies, Markets, and Companies" is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.
For more information and to order see:
Malachite Management has joined forces with an established and reputable author to bring you a report outlining the very latest in the Gene Therapy industry. "Gene Therapy - Technologies, Markets and Companies" is 560 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information and to order see:
Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1 Vol. 2
Gene Therapy Order Form
Malachite Management Inc. has teamed up with an established publisher to bring you the latest reports in immunotherapeutic approaches to cancer. For more information and to order see:
A Shift in Cancer Immunotherapy Stategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents
Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future PerspectivesTable of Contents
Immunotherapy Reports Order Form
MultiCell Gains Japanese Pharma Licensee for Its Proprietary Hepatocytes
Immunoassay Market in Japan, Fuji Keizai Releases Report
Norak Biosciences and Curis Sign Research Agreement
Under terms of the agreement, Norak will utilize its proprietary Transfluor Technology, related intellectual property and scientific expertise to developed Transfluor cell lines expressing Curis' receptors.
TxCell Raises EUR10.5 Million Series A To Finance Phase I-IIA Clinical Trials
Targeted Genetics Named One Of Washington State's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program
Dallas-based Law Firm Winstead Sechrest & Minick PC Centers Biotech Group in Houston
Biological Breakthrough in Stem Cell Research Backed by Gulf Investors
For Job Stimulus, Boston Mulls Direct Investments
Boston officials are considering plans to invest city funds directly into biotechnology companies, part of a broader effort to stimulate the hot industry within city limits and create jobs.
DNA Pioneer James Watson Defends Stem Cell Research
New Genome and Biomedical Sciences Facility at the University of California, Davis Promotes Cross-Cutting Research
National Institutes of Health
Center for Scientific Review Special Emphasis
Panel, Stem Cell Therapy and Ion Channels in the Heart.
Date: 10:30 a.m. to 12 p.m. October 29, 2004, Bethesda, MD
Agenda: To review and evaluate grant applications.
Contact Person: Anshumali Chaudhari, PhD, Scientific Review
Novel Approaches to Enhance Animal Stem Cell Research
(PA-04-125) Expiration date: November 2 2007, unless reissued
National Center for Research Resources, National Cancer Institute, National Eye Institute, National Heart, Lung and Blood Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Biomedical Imaging and Bioengineering, National Institute of Child Health and Human Development, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Institute on Deafness and Other Communication Disorders, National Institute on Drug Abuse,
APPLICATION RECEIPT DATE(S): Multiple dates, see announcement
NIH Funds Centers to Study Islet Transplantation
All new CBER information can be reached from the What's New page
Guidance for Industry: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately Reduce the Risk of Transmission of HIV-1 and HCV - 10/21/2004
Scientific Opportunities for Facilitating Development of Blood and Blood Products
CBER Critical Path Workshop (Slides)
Posted: 10/15/2004, Workshop Date: 10/7/2004
2004 Biological Approvals - Update
Posted: 10/14/2004, Updated through: 9/30/2004
ISPE Regulatory Information (International regulatory agencies and documents)
International Conference on Harmonisation (ICH) Guidances - Topics and Guidelines
The 21CFRPart11.com Web site provides access to information on the rules and also maintains an email list that actively discusses issues and concerns with industry peers and government regulators.
The FDA home page
The FDA Dockets
The FDA Modernization Act of 1997 (FDAMA)
Regulatory Affairs Professionals Society
RAPS Combination Products Resource Page.
OTHER REGULATORY RESOURCES
Advanced Cell and Gene Therapy Consulting
Biologics Regulatory Training Institute
The Biologics Consulting Group
Plan to attend the symposium "Cellular Therapy: Progressing to Clinical Practice?", which takes place on Friday, December 3, 2004.
Location: San Diego Marriott Hotel & Marina, San Diego, CA
For more information or to pre-register online go to Click Here
Sponsored by Zenalta and supported by Miltenyi Biotec and Kirin Corporate Symposium
MALACHITE'S ONLINE CONFERENCE CALENDAR
For a more complete listing of conferences, see Malachite Management's new online, interactive Cell Therapy Calendar
OTHER ONLINE CALENDARS
Oct. 23-26 Amer. Assoc. of Blood Banks Annual Meeting - Baltimore, Maryland.
Oct. 26-30 American Society of Human Genetics (ASHG) 54th Annual Meeting. Toronto, Canada.
Oct 29, 2004 (7:30 AM - 7:00 PM) Biotech & Life Sciences Global Venture Congress 2004. Madison Square Garden, New York
Nobel Laureate Dr. James Watson Keynote Speaker with 20 top-tier Biotech Venture Capitalists
Nov. 3-6 4th Annual Stem Cell Network Annual General Meeting, Montreal, Canada.
Nov. 4-6 BioStar Congress in Stuttgart, Germany
Nov. 4-7. European Society of Gene Therapy (ESGT) 12th Annual Meeting. Tampere, Finland.
Nov. 10-12 2nd Annual International Clinical Trials Summit, Westin Grand Hotel, Washington, DC
Nov. 17-20 7th International congress of the Cell Transplant Society. Boston, MA.
Nov.18-19 Commercialisation of Tissue Engineering and Regenerative Medicine. London, UK.
Nov. 19 Advances In Bone Marrow Transplantation Conference- Sydney Australia
Nov. 19 - 21 2004 Hanson Symposium "Stem Cells: From Biology to Therapy". Adelaide, South Australia.
Nov. 22-24 2nd National Stem Cell Centre Annual Scientific Conference. Sydney, Australia.
Dec. 1-3 Immunogenicity for Protein-Based Therapeutics - Washington, DC
Dec. 3 Cellular Therapy: Progressing to Clinical Practice?- San Diego Marriott Hotel & Marina, San Diego, CA
Dec. 3-7 Amer. Society for Hematology: 46th Annual Mtg - San Diego, California - San Diego, CA
Dec. 4-8 American Society for Cell Biology (ASCB) 44th Annual Meeting. Washington, D.C.
Dec. 9-10 DIA/EMEA Workshop on Gene Therapy & Cell Therapy Products. London, UK.
Oct. 5-Nov. 15 The Zitter Group: Managed Care Webcast Series - New series for biotech and pharma marketers aiming to enhance reimbursement, coverage, managed care strategy, and tactical effectiveness.
Oct. 26 Inside FDA’s New cGMP Guidance: Map Your Quality System to the Requirements
Nov. 5 Analytical Validation and Regulatory Compliance Issues for the Pharma, Biotech, Medical Device and Related Industries - San Francisco, California.
Nov. 29-Dec. 1: Current Good Tissue Practice- Amsterdam, Netherlands
Nov. 30-Dec. 1: Monitoring Clinical Trials - Malvern, Pa.
cGMP in the Transfusion Service. An online training course. link
NIH and other stem stem cell training courses - link
Weekly - UCSFs Human Embryonic Stem Cell Training Program (3-day training course). link
Jan. 24-26 Phacilitate Cell & Gene Therapy Forum. Washington DC
Feb. 10-14 Tandem BMT Meetings (Combined ASBMT and IBMTR/ABMTR annual meetings). Keystone, Colo.
Feb. 23-25: The Clinical Trials Congress - Philadelphia
Featuring 80+ leading clinical experts incorporating Clinical Technologies, Patient Recruitment, Regulations, Strategic Partnerships, Study Design & Management and Contracts and Budgeting into 4 dynamic tracks. Janet Woodcock, MD, CBER, FDA provides a highly-anticipated update on the FDA Clinical Path Initiative.
March 16-20 American Society of Transplantation (AST) and Canadian Society of Transplantation (CST) Annual Winter Symposium. Banff, Canada.
March 20–23 European Group for Blood & Marrow Transplantion Annual Mtg. Prague, Czech Republic.
April 27-30 American Society for Apheresis 26th Annual Meeting Chicago, IL.
May 18-20 2nd World Congress on Regenerative Medicine. Leipzig, Germany.
May 3-7. 11th Annual Meeting and Scientific Conference of the International Society for Cellular Therapy (ISCT) Vancouver, Canada. (combined with Good Tissue Practices Workshop & Flow Cytometry for HSC Transplantation Workshop)
June 1-5 American Society of Gene Therapy Annual Meeting. Saint Louis, MO.
June 23-25 3rd Annual Meeting of the International Society for Stem Cell Research. San Francisco, CA.
Sept. 21-25 International Society of Pediatric Oncology Conference. Vancouver, Canada.
Sept/Oct Second International Epithelial Mesenchymal Transfer Conference. Vancouver, Canada.
Read Cytotherapy in 2005!
Join ISCT ($130) and receive the journal as a benefit of membership
Volume 6, Number 5 / October 2004
Table of Contents
Stem Cell Transplants For Heavily Transfused Patients With Severe Aplastic Anemia – A Promising New Strategy.
Review: An Antigen-Presenting Cell (APC) For Every Occasion: Induction And Expansion Of Human Antigen-Specific CD4 And CD8 T Cells Using Cellular And Non-Cellular APC.
Radiotherapy-Based Conditioning Is Effective Immunosupression For Patients Undergoing Transplantation With T-Cell Depleted Stem Cell Grafts For Severe Aplasia.
Comparison Of Total Nucleated Cell Measurements Of Umbilical Cord Blood Samples Using Two Hematology Analyzers.
Role of Beta 1-Integrins And Their Associated Tetraspanin Molecules In Fibronectin Enhanced Megakaryopoiesis. .
Mesenchymal Stem/Progenitor Cells Developed In Cultures From Umbilical Cord Blood.
Activated Platelets Rapidly Upregulate CD40L Expression And Can Effectively Mature And Active Autologous, Ex Vivo Differentiated Dendritic Cells.
Impaired Peripheral Blood Progenitor Cell Collection In Patients With Myeloma After High-Dose Melphalan.
Real Time Process/Quality Control For Hematopoietic Progenitor Cell Processing.
Expansion of Human Cytomegalovirus-Specific Cytotoxic T Lymphocytes To a Clinical Scale: A Simple Culture System Using Tetrameric HLA-Peptide Complexes.
Intraoperative Isolation and Processing Of Bone Marrow Derived Stem Cells.
Cytotherapy publishes original research, reviews, meeting reports, special focus issues and letters in the general field of cell therapy. The scope of the journal includes includes basic and applied research with hematopoietic and non-hematopoietic stem cells , immune cells, and antigen-presenting cells. Therapeutic topics within the scope of Cytotherapy include ex-vivo and in-vivo aspects of gene therapy, immunotherapy, stem cell transplantation and tissue regeneration. Cytotherapy particularly welcomes
contributions from researchers, clinicians, technicians and individuals involved in regulatory aspects of cell therapy.